Clinical Features and Genomic Epidemiology of Bloodstream Infections due to Enterococcal Species Other Than Enterococcus faecalis or E. faecium in Patients With Cancer
Open Access
- 17 May 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (6) , ofae288
Abstract
Non–Enterococcus faecium, non–E. faecalis (NFF) enterococci are a heterogeneous group of clinically pathogenic enterococci that include species with intrinsic low-level vancomycin resistance. Patients with cancer are at increased risk for bacteremia with NFF enterococci, but their clinical and molecular epidemiology have not been extensively described. We conducted a retrospective review of all patients (n = 70) with NFF bacteremia from 2016 to 2022 at a major cancer center. The main outcomes assessed were 30-day mortality, microbiological failure (positive blood cultures for ≥4 days), and recurrence of bacteremia (positive blood culture E. gallinarum (50%) and E. casseliflavus (30%). Most (61%) patients received combination therapy. Bacteremia recurred in 4.3% of patients, there was a 30-day mortality of 23%, and 4.3% had microbiological failure. E. gallinarum and E. casseliflavus isolates were genetically diverse with no spatiotemporal clustering to suggest a single strain. Frequencies of ampicillin resistance (4.3%) and daptomycin resistance (1.9%) were low. Patients with hematologic malignancy had infections with NFF enterococci that harbored more resistance genes than patients with solid malignancy (P = .005). NFF bacteremia is caused by a heterogeneous population of isolates and is associated with significant mortality. Hematological malignancy is an important risk factor for infection with NFF resistant to multiple antibiotics.Keywords
Funding Information
- NIH
- NIAID (K24AI121296, R01AI134637, R01AI148342–01, P01AI152999, T32AI141349, L30AI154520, T32AI141349)
- Houston Methodist Clinical Scholars (K01AI148593–01, P01AI152999)
- W.R.M. (K08AI135093, R21AI175821)
This publication has 32 references indexed in Scilit:
- Nosocomial outbreak of Enteroccocus gallinarum: untaming of rare species of enterococciJournal of Hospital Infection, 2008
- Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06Journal of Antimicrobial Chemotherapy, 2008
- Accuracy of Six Antimicrobial Susceptibility Methods for Testing Linezolid against Staphylococci and EnterococciJournal of Clinical Microbiology, 2007
- Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002–2005)Diagnostic Microbiology and Infectious Disease, 2007
- Risk Factors and Outcomes Associated With Non–Enterococcus faecalis, Non–Enterococcus faeciumEnterococcal BacteremiaInfection Control & Hospital Epidemiology, 2006
- Clinical Features and Outcomes of Bacteremia Caused byEnterococcus casseliflavusandEnterococcus gallinarum:Analysis of 56 CasesClinical Infectious Diseases, 2004
- Clinical and Epidemiological Features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum Bacteremia: A Report of 20 CasesClinical Infectious Diseases, 2001
- Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group.1999
- Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a d-alanine:d-alanine ligase-related protein necessary for vancomycin resistanceGene, 1992
- Vancomycin susceptibility and identification of motile enterococciJournal of Clinical Microbiology, 1991